CDC25A and acute myeloid leukemia: 2. The AML cells showed accumulation of CDC25A; pharmacological inhibition or siRNA-mediated downregulation of CDC25A impaired adhesion-dependent proliferation. CDC25A accumulation was CDH1 dependent and due to modified proteasomal degradation.